VCAM1 and metabolic dysfunction-associated steatohepatitis: We hypothesized that VCAM-1 in HSCs could regulate the accumulation of leukocyte populations in the liver microenvironment during NASH, or regulate intracellular signaling processes involved in HSC transdifferentiation into myofibroblasts.